首页> 美国卫生研究院文献>Acta Cardiologica Sinica >Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

【2h】

Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

机译：低剂量达比加群和利伐沙班对非瓣膜性房颤患者的有效性和安全性的直接比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background We aimed to examine the comparative effectiveness and safety between low-dose dabigatran and rivaroxaban in atrial fibrillation (AF) patients.

机译：背景我们旨在研究低剂量达比加群和利伐沙班在房颤患者中的相对有效性和安全性。

著录项

期刊名称 Acta Cardiologica Sinica
作者
Shih-Wei Meng; Ting-Tse Lin; Min-Tsun Liao; Ho-Min Chen; Chao-Lun Lai;
展开▼
作者单位

展开▼
年(卷),期 2019(35),1
年度 2019
页码 42–54
总页数 13
原文格式 PDF
正文语种
中图分类
关键词
Anticoagulant Dabigatran Death Effectiveness Rivaroxaban Safety;

机译：抗凝剂;达比加群;死亡;有效性;利伐沙班;安全性;

相似文献

外文文献
中文文献
专利

1. Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation [J] . Andersson Niklas W., Svanstrom Henrik, Lund Marie, International Journal of Cardiology . 2018,第期

机译：非瓣膜心房颤动患者Apixaban，Dabigatran和Rivaroxaban的比较效果和安全性
2. Comparison of cost-effectiveness of anticoagulation with dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation across countries [J] . KrejczyM., HarenbergJ., MarxS., Journal of thrombosis and thrombolysis . 2014,第4期

机译：各国非瓣膜性心房颤动患者使用达比加群，利伐沙班和阿哌沙班抗凝的成本效益比较
3. Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation [J] . Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2020,第期

机译：含有Apixaban，Dabigatran和Rivaroxaban在心房颤动的疗效和安全性的直接比较
4. Epicardial Pulmonary Vein Isolation By Cryoablation As Concomitant Cardiac Surgery To Treat Non-valvular Atrial Fibrillation "Lavie Technique" [C] . H. Kubota, M. Sato, T. Fujiki, World Congress on Cardiac Pacing and Electrophysiology . 2003

机译：心外膜肺静脉隔离通过冷冻剂作为伴随心脏手术治疗非瓣膜心房颤动“Lavie技术”
5. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for the prevention of stroke prophylaxis in atrial fibrillation. [D] . Harrington, Amanda. 2012

机译：阿哌沙班，达比加群，利伐沙班和华法林预防房颤预防中风的成本效益。
6. Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system [O] . Todd C Villines, Azhar Ahmad, Michaela Petrini, -1

机译：达比加群与利伐沙班和阿哌沙班在非瓣膜性房颤患者中的比较安全性和有效性：来自大型医疗系统的回顾性研究
7. P3844Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population [O] . A Amin, A Keshishian, Q Zhang, 2018

机译：P3844紫杉醇，Dabigatran，Rivaroxaban的P3844效应，安全性和复合临床结果，相对于美国医疗保险人群的非瓣膜心房颤动患者的华法林

Direct Comparison of Low-Dose Dabigatran and Rivaroxaban for Effectiveness and Safety in Patients with Non-Valvular Atrial Fibrillation

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅